H.R. 9127 · 117th Congress · House

Mandating Exclusive Review of Individual Treatments (MERIT) Act

Active· Referred to the Subcommittee on Health.
Introduced
Oct 4, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.

Action Timeline

5
  1. OCT 05, 2022•Committee

    Referred to the Subcommittee on Health.

  2. OCT 04, 2022•IntroReferral

    Introduced in House

  3. OCT 04, 2022•IntroReferral

    Introduced in House

  4. OCT 04, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. OCT 04, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Health Subcommittee

hsif14

Referred: Oct 5, 2022

Active

Ways and Means Committee

hswm00

Referred: Oct 4, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Oct 4, 2022

Active